| Standard Report | Premium Report | |
|---|---|---|
| Current State of the Industry |  |
|
| Market Size (industry trends) | |
|
| Market Forecast (5-year projection) | |
|
| Products/Services Breakdown | |
|
| Revenue per State | |
|
| Financial Metrics | |
|
| Salary & Compensation Statistics | |
|
| Public Company Information | |
|
| Key Private Companies | |
|
| Government Vendors | |
|
| Instant Download - Available immediately upon purchase | |
|
Download both PDF and Excel
|
|
|
| Download now: |
2025 U.S. Industry Statistics & Market Forecast - Research and Development in Biotechnology
Market Size & Industry Statistics
The total U.S. industry market size for Research and Development in Biotechnology :
Industry statistics cover all companies in the United States, both public and private, ranging in size from small businesses to market leaders.
In addition to revenue, the industry market analysis shows information on employees, companies, and average firm size.
Investors, banks, and business executives use growth rates and industry trends to understand the market outlook and opportunity.
| Statistics | 2020 2021 2022 2023 2024 | |
|---|---|---|
| Market Size (Total Sales/Revenue) |
Order at top of page | |
| Total Firms | ||
| Total Employees | ||
| Average Revenue Per Firm | ||
| Average Employees Per Firm | ||
| Average Revenue Per Employee | ||
Market Forecast
Market forecasts show the long term industry outlook and future growth trends. The following extended five-year forecast projects both short-term and long-term trends.
| Forecast / Industry Outlook | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| Market Forecast ($ millions) | |||||
| Projected Industry Growth Rate (%) | |||||
Industry Insights
Major trends affect the Research and Development in Biotechnology industry include:- Increased funding for biotechnology startups
- Rising demand for personalized medicine
- Advancements in CRISPR and gene editing technologies
- Integration of artificial intelligence and machine learning
- Emphasis on sustainable biotech solutions
- Growth in biologic drugs development
- Expansion of synthetic biology applications
- Collaborations between academia and industry
- Regulatory changes impacting biotech innovation
- Focus on rare diseases and orphan drugs
- Ethical considerations in genetic research
- Impact of global health crises on R&D priorities
- Adoption of automation and robotics in research labs
- Increasing importance of data security and privacy
- Shift towards patient-centric healthcare models
U.S. Geographic Distribution: Revenue Statistics by State
Market Size by State ($ millions) indicates how the industry's competition is distributed throughout the country. State-level information can identify areas with higher and lower industry market share than average.
Income Statement (Average Financial Metrics)
Financial metrics provide a snapshot view of a benchmark "average" company. Key business metrics show revenue and operating costs. The data collected covers both public and private companies.| Industry Average | Percent of Sales (Industry Benchmark) |
|
|---|---|---|
| Total Revenue | Order at top of page |
|
| Operating Revenue | ||
| Cost of Goods Sold | ||
| Gross Profit | ||
Operating Expenses | ||
| Pension, profit sharing plans, stock, annuity | ||
| Repairs | ||
| Rent paid on business property | ||
| Charitable Contributions | ||
| Depletion | ||
| Domestic production activities deduction | ||
| Advertising | ||
| Compensation of officers | ||
| Salaries and wages | ||
| Employee benefit programs | ||
| Taxes and Licenses | ||
| Bad Debts | ||
| Depreciation | ||
| Amortization | ||
| Other Operating Expenses | ||
| Total Operating Expenses | ||
| Operating Income | ||
| Non-Operating Income | ||
| EBIT (Earnings Before Interest and Taxes) | ||
| Interest Expense | ||
| Earnings Before Taxes | ||
| Income Tax | ||
| Net Profit Net Income | ||
Financial Ratio Analysis
Financial ratio information can be used to benchmark how a Research and Development in Biotechnology company compares to its peers. Accounting statistics are calculated from the industry-average for income statements and balance sheets.| Profitability & Valuation Ratios | Industry Average |
|---|---|
| Company valuation can be measured based on the firm's own performance, as well as in comparison against its industry competitors. These metrics show how the average company in the Research and Development in Biotechnology industry is performing. | |
| Profit Margin Gross Profit Margin, Operating Profit Margin, and Net Profit Margin. Show company earnings relative to revenues. |
|
| Return on Equity (ROE) Return on Equity (ROE) is net income as a percentage of shareholders' equity. Shareholders' Equity is defined as the company's total assets minus total liabilities. ROE shows how much profits a company generates with the money shareholders invested (or with retained earnings). |
|
| Return on Assets (ROA) Return on Assets (ROA) is net income relative to total assets. The market research on Research and Development in Biotechnology measures how efficiently the company leverages its assets to generate profit. ROA is calculated as Net Income divided by Total Assets. |
|
| Liquidity Ratios | Industry Average |
|---|---|
| Bankers and suppliers use liquidity to determine creditworthiness and identify potential threats to a company's financial viability. | |
| Current Ratio Measures a firm's ability to pay its debts over the next 12 months. |
|
| Quick Ratio (Acid Test) Calculates liquid assets relative to liabilities, excluding inventories. |
|
| Efficiency Ratios - Key Performance Indicators | Industry Average |
|---|---|
| Measure how quickly products and services sell, and effectively collections policies are implemented. | |
| Receivables Turnover Ratio If this number is low in your business when compared to the industry average in the research report, it may mean your payment terms are too lenient or that you are not doing a good enough job on collections. |
|
| Average Collection Period Based on the Receivables Turnover, this estimates the collection period in days. Calculated as 365 divided by the Receivables Turnover |
|
| Inventory Turnover A low turnover rate may point to overstocking, obsolescence, or deficiencies in the product line or marketing effort. |
|
| Fixed-Asset Turnover Generally, higher is better, since it indicates the business has less money tied up in fixed assets for each dollar of sales revenue. |
|
Compensation & Salary Surveys for Employees
Compensation statistics provides an accurate assessment of industry-specific jobs and national salary averages. This information can be used to identify which positions are most common, and high, low, and average annual wages.| Title | Percent of Workforce | Bottom Quartile | Average (Median) Salary | Upper Quartile |
|---|---|---|---|---|
| Management Occupations | 19% | Order at top of page |
||
| Chief Executives | 1% | |||
| General and Operations Managers | 4% | |||
| Operations Specialties Managers | 5% | |||
| Other Management Occupations | 8% | |||
| Business and Financial Operations Occupations | 11% | |||
| Business Operations Specialists | 9% | |||
| Computer and Mathematical Occupations | 15% | |||
| Computer Occupations | 12% | |||
| Software and Web Developers, Programmers, and Testers | 7% | |||
| Software Developers | 5% | |||
| Architecture and Engineering Occupations | 15% | |||
| Engineers | 12% | |||
| Life, Physical, and Social Science Occupations | 22% | |||
| Life Scientists | 11% | |||
| Biological Scientists | 5% | |||
| Medical Scientists | 5% | |||
| Medical Scientists, Except Epidemiologists | 5% | |||
| Life, Physical, and Social Science Technicians | 6% | |||
| Office and Administrative Support Occupations | 6% | |||
Research and Development in Biotechnology Competitor Landscape & Key Companies [PREMIUM]
The most influential companies in the Research and Development in Biotechnology industry and adjacent industries either have large market share or are developing new business models and methods that could disrupt the status quo. We look at leading and emerging companies in the Research and Development in Biotechnology industry and adjacent sectors:| Market Leaders: Direct Competitors Companies with the largest market share, focused in this industry |
Market leaders: Diversified Competitors Largest companies that have diversified operations in this and other industries |
| Innovators: Direct Competitors Innovative, Emerging, and Disruptive Companies that may influence the future direction of the industry. |
Innovators: Diversified Competitors Innovators and Disruptors in adjacent industries that may also affect the Research and Development in Biotechnology industry. |
Source:
Latest Industry News
- Biotech Start-Ups Jump to 11,000 in India - Here's How Govt Is Helping New Ventures - India’s biotech ambitions are translating into real market traction. Startups like Paramesu Biotech and Zerocircle are attracting investor attention and raising fresh capital, while government-backed (07/08/2025)
- Chugai enters into joint research and license accord with Gero - Japanese drugmaker Chugai Pharmaceutical has entered into a joint research and license agreement to develop novel therapies for age-related diseases with Singapore-based biotech Gero. (07/07/2025)
- Biotech in Vienna: a budding life science hub - Vienna’s biotech sector soared to €22.7B in 2023, fueling innovation, research, and jobs. Discover what is driving the boom. (07/07/2025)
- Chugai and Gero Enter into Joint Research and License Agreement to Develop Novel Therapies for Age-Related Diseases - Collaboration to create novel antibody drug candidates using Chugai's proprietary antibody engineering technologies for drug targets identified through Gero's AI-driven human data-first platformAccelerating the creation of innovation by combining Gero's aging-focused target discovery technology with Chugai's drug discovery technologies TOKYO, (07/07/2025)
- Sun Pharma Advanced Research Company incorporates wholly owned subsidiary Genokine Biotech - Mumbai: Sun Pharma Advanced Research Company Limited (SPARC) has announced the incorporation of its wholly owned subsidiary, Genokine Biotech Limited. The new entity was officially incorporated (07/07/2025)
- NIH budget cuts threaten the future of biomedical research — and the young scientists behind it - NIH budget cuts are threatening key medical research programs, shrinking training grants, and leaving young researchers facing career uncertainty. (07/06/2025)
- Biotechnology key to advancing sustainable agriculture: Experts - To enhance productivity, quality, and the added value of products while safeguarding the environment, the agricultural sector should prioritize the development of biotechnology. (07/05/2025)
- RDI scheme fund to be deployed in sunrise sectors such as energy, biotechnology, deep tech, and defence - Research, Development and Innovation (RDI) scheme targets long-gestation, high-risk technologies via flexible capital routed through ANRF, says Abhay Karandikar, Secretary of the Department of Science and Technology. (07/03/2025)
- Shionogi puts more than $600M on the table for Swiss biotech's antibiotic program - Storied Japanese pharma Shionogi is upping its arsenal in the fight against antibiotic resistance. | Storied Japanese pharma Shionogi is upping its arsenal in the fight against antibiotic resistance. (07/02/2025)
- Thermo Fisher-Tufts Study Links CRO-CDMO Platform to Shorter Cancer Drug Development Timeframe - Thermo Fisher Scientific’s Accelerator™ Drug Development solutions, which integrate services for contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs), (06/29/2025)
Related Reports
Can't find what you're looking for? We have over a thousand
market research reports.
Ask us and an analyst will help you find what you need.